Home > Boards > US Listed > Biotechs >

Biotron (BITRF)

Add BITRF Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/2/2022 3:05:58 AM - Followers: 10 - Board type: Free - Posts Today: 0

Biotron (BITRF)

Biotron (BITRF), the MOST UNDERVALUED biotech across all markets! Bioton (BITRF) has been quietly developing a new class of anti-viral drugs for the treatment of HIV-1 and Hepatitis C. Biotron (BITRF) is now well advanced in its clinical programs and results to date have been awesome! 7 Clinical trials have now been completed with positive data recorded in all trials!
On Feb 6th, 2017 Biotron (BITRF) released phenomenal results from it's latest study that showed it's lead pipeline drug BIT225 significantly reduces HIV-1 viral loads from the system beyond the current best anti-retroviral treatments for HIV-1. Meaning BIT225 is more EFFECTIVE than any approved drug treatment that's available today but even more significant it helped not only cure but ERADICATE HIV-1 from the system! 
A commercial outcome based on Biotron (BITRF) current and anticipated results is expected! The company stated that it's latest positive trial results were to be shared in confidence with potential commercial partners (BIG PHARMA). This is a multi BILLION dollar market and Biotron (BITRF) is FIRST IN CLASS
Trading around 3 cents a share, and with it's spectacular successful trials, Biotron (BITRF), the MOST UNDERVALUED biotech across all markets! NOW is the time to buy shares of Biotron (BITRF) before it likely gets acquired by a global pharmaceutical company!

Highlights for Biotron (BITRF)
Biotron (BITRF) is a publicly listed Australian Biotechnology Company based in Sydney, Australia.
Biotron (BITRF) is current in it's filings and trades on the OTC Markets, it also trades on the Australian ASX

Biotron Limited is engaged in the research, development, and commercialisation of drugs targeting significant viral diseases with unmet medical need. Biotron’s core expertise is the design and development of new anti-viral drugs targeting viral ion channel proteins (viroporins). Viroporins are present in broad range of viruses such as Dengue, Hepatitis B, Ebola, Middle East Respiratory virus, Influenza and Zika viruses! 
The Company has BIT225 in clinical development for both HIV-1 and Hepatitic C (HCV) and also has several earlier stage preclinical and research programs designing drugs that target Dengue, Hepatitis B, Ebola, Middle East Respiratory virus, Influenza and Zika viruses. 


In stunning success news released on it's latest study on Feb 6th, 2017 showed it's lead pipeline drug BIT225 significantly reduces HIV-1 viral loads from the system beyond the current best anti-retroviral treatments for HIV-1. Meaning BIT225 is MORE EFFECTIVE than any approved drug treatment that's available today!

The study also demonstrated that adding BIT225 to anti-retroviral treatment results in a delayed and slower rate of viral rebound when anti-viral drugs are stopped. Meaning that that BIT225 treatment may lead to ERADICATION of one the key underlying viral reservoirs thus eliminating HIV-1 from the system for good! Also known as a complete CURE! 

While existing drugs may help control the virus, they can’t kill it, big-pharmas have for years attempted to find a cure for HIV-1, today Biotron (BITRF) is now on the threshold of demonstrating it's new class of antiviral pipeline drugs not only cure but ERADICATE HIV-1.

Based upon the positve result Biotron (BITRF) has announced BIT225-009 Phase 2 human clinical trials, will be EXPEDITED!

Biotron (BITRF) stated that the latest successful trial results will be presented in detail as soon as possible and shared in confidence with potential commercial partners. (BIG PHARMA)


Biotron (BITRF) lead pipeline drug BIT225 has demonstrated in pre-clinical and clinical studies to date, to also have a positive impact on chronic hepatitis C infection (HPV).

Incredibly BIT225 is just one in Biotron (BITRF) library of hundreds of compounds! AMAZING PIPELINE POTENTIAL!


An estimated 2.4 million patients in the USA and Europe are infected with HIV-1, with 91,000 new cases each year. Globally, 130 - 150 million people have chronic hepatitis C infection. That number also continues to grow daily. 
Biotron (BITRF) lead pipeline BIT225 is a valuable Phase 2 asset with two indications – HIV-1 and HCV Both are multi-billion dollar markets and Biotron (BITRF) is FIRST IN CLASS!

Biotron (BITRF) is leading the field and is dominant in it's successful trials! Biotron’s viroporin targeting approach to drug development is working with spectacular results!

Over 200 individuals dosed (healthy, HCV, HIV-1 and HIV-1/HCV co-infected) in trials 

7 clinical trials completed - positive data recorded in all trials 

Demonstrated clinical activity against HCV GT1 and GT3 

Positive data readout from BIT225-008 GT1 data earlier in year 
HCV drugs Data generated in HCV trials is also applicable to HIV-1 program 

Comprehensive data package on BIT225 completed (manufacturing, safety profile, PK, efficacy, dosage, etc) for regulatory filings and to support combination studies with potential partners












Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#77   BIT225 EFFECTIVE AGAINST ESTABLISHED SARS-CoV-2 IN ANIMALS Fingers xed 05/02/22 03:05:58 AM
#76   CONFIRMATION OF BIT225 EFFECTIVENESS AGAINST Fingers xed 03/17/22 09:12:20 AM
#75   Coronavirus pandemic makes Biotron Limited a good pick Stockfun1 03/08/20 03:36:39 PM
#74   Biotron moving on Prospects of Coronavirus vaccine. Stockfun1 02/08/20 09:56:18 AM
#73   Echo! Anyone there awaiting some action? Saphoroth 05/29/19 02:18:58 AM
#72   open an account at a brokerage firm that Rocketstockpix 12/10/18 09:18:18 AM
#71   Sorry for the repeat posting of the article Stockfun1 11/24/18 08:22:51 PM
#65   Check the latest article below Highlighting Biotron. Stockfun1 11/23/18 02:20:24 AM
#64   This may sound dumb to those on this Stockfun1 11/18/18 01:30:02 AM
#63   Naples , Florida here !! misiu143 11/13/18 03:26:56 PM
#62   Great, I am in the Sacramento CA area. united4ever 11/13/18 03:26:19 PM
#61   Thank you , I am investing since few misiu143 11/13/18 03:16:38 PM
#60   Your welcome. Someone on the board of another united4ever 11/13/18 03:10:40 PM
#59   Thank you , if that will happen it misiu143 11/13/18 11:48:18 AM
#58   This was the Announcement https://hotcopper.com.au/threads/ann-presentation-of-b united4ever 11/13/18 11:39:16 AM
#57   Well , actually we don’t really know in misiu143 11/11/18 11:40:55 PM
#56   Huge potential with novel compound and great phase Stockfun1 11/11/18 05:37:21 PM
#55   I've found this site has a good collection searching4rainbow 11/06/18 09:36:44 AM
#54   Hello everyone what’s the deal with this stock Mrvince 11/06/18 08:09:49 AM
#53   (BITRF BiotronLTD) NEW ISSUE ANNOUNCEMENT 25 October Dougster 10/25/18 05:43:56 PM
#52   Thanks United. Good information. I don’t feel Stockfun1 10/20/18 09:54:18 AM
#51   US dollar is $1.40 Australian. Therefore 20 cents united4ever 10/19/18 09:20:46 PM
#50   Those who are not familiar Biotron Limited and Stockfun1 10/19/18 05:49:14 PM
#49   Who ever is holding this stock back please Stockfun1 10/19/18 01:51:55 PM
#48   They still analyzing phase 2 study for HIV. misiu143 10/16/18 09:05:06 AM
#47   Although you only need one indication to catch Stockfun1 10/16/18 07:20:22 AM
#46   I have been a shareholder for 2 weeks united4ever 10/15/18 12:18:04 PM
#45   And I hope that you are right because misiu143 10/14/18 02:41:49 PM
#44   Not a stretch. They’ve already been communicating Stockfun1 10/14/18 02:38:06 PM
#43   I’ve done my research but I can’t find Stockfun1 10/14/18 02:34:44 PM
#42   $ holding this payed off huge ;) ArsenalProfits 10/12/18 01:24:25 PM
#41   Thank you , very nice update misiu143 10/09/18 07:53:00 AM
#40   feels like a deal is near , it Holmesy 10/09/18 04:09:02 AM
#39   Bloomberg Markets How an HIV Trial Triggered a 667% Jump Stockfun1 10/05/18 07:57:31 PM
#38   Leronlimab...sorry. misiu143 10/03/18 03:36:49 PM
#37   It is a little stretch for now ...imo...... misiu143 10/03/18 01:57:08 PM
#36   Australian clincal trial show positive results for possible Stockfun1 10/03/18 01:16:31 PM
#35   That posting was 20 months ago or so. Traderfan 10/03/18 10:04:25 AM
#34   Obviously who ever posted this last message hasn’t Stockfun1 10/03/18 01:43:33 AM
#33   Another complete failure here. Traderfan 03/23/17 05:03:40 PM
#32   Same here. I been slowing adding a bit. ArsenalProfits 03/02/17 09:49:20 AM
#31   Not sure, i bought some and sittin on it! MrTrader129 02/28/17 08:59:46 AM
#30   Is this puppy still alive lol puffadder 02/27/17 01:50:32 PM
#29   Pistol Pete.. Chaka 02/19/17 05:02:06 AM
#28   $BITRF One Month Chart http://www.stockscores $Pistol Pete$ 02/17/17 01:01:14 AM
#27   Me too. Hidden gem here. $1K to up2parTrader 02/17/17 12:23:24 AM
#26   Took a position ArsenalProfits 02/16/17 02:08:01 PM
#25   Ghost town on here! Anyone out there? MrTrader129 02/15/17 02:05:25 PM
#24   NO STOCK SECTORS goes BOOM like biotech sector. Chaka 02/14/17 04:59:53 PM
#23   BITRF is really @ GROUND FLOOR level... Chaka 02/14/17 04:53:09 PM
Consent Preferences